Yang Yi, Wu Ziwei, Xu Junfang, Dong Hengjin
Department of Science and Education of the Fourth Affiliated Hospital, and Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, China.
Center for Health Policy Studies, School of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, China.
J Family Med Prim Care. 2025 Jun;14(6):2131-2137. doi: 10.4103/jfmpc.jfmpc_1344_24. Epub 2025 Jun 30.
Perceived economic burden and health-related quality of life (HRQOL) of patients with colorectal cancer after surgery are limited, which is benefit for understanding the health status of colorectal cancer patients, providing evidence for developing intervention measures, improving prognosis, and enhancing quality of life of patients.
A questionnaire-based online investigation was used to collect data from patients with colorectal cancer after surgery between November 2023 and March 2024. The severity of colorectal cancer was categorized to phases 1, 2, 3, and 4 based on the Chinese Society of Clinical Oncology Colorectal Cancer Diagnosis and Treatment Guidelines 2022 Edition. HRQOL was measured using EQ-5D-5L Chinese version. We obtained the health utility value through the integral conversion system, which assigns weights to different levels of the five health dimensions in the EQ-5D-5L scale. Univariate and multivariate logistic regressions were used to analyze the associated factors of utility and VAS score.
227 patients were investigated and incorporated to the data analysis. The mean age of the patients was 63.55 ± 11.71 years old with the average personal annual income of 60000 RMB. As the cancer progresses, different dimensions of HRQOL showed a trend of deterioration. More patients had slight problems in the dimension of pain/discomfort, followed by anxiety/depression, usual activities, self-care and mobility. The EQ-VAS score among colorectal cancer was 87.99, 90.85, 77.04 and 78.28 in phases 1, 2, 3 and 4, respectively ( = 0.000, X = 63.036). The utility score among colorectal cancer was 0.9443, 0.9632, 0.8759 and 0.8494 in phases 1, 2, 3 and 4, respectively ( = 0.000, X = 44.668). Compared to the phase 1, phases 3 and 4 were significantly related to the lower utility and VAS score. Having commercial health insurance was statistically with higher VAS score ( = 0.029). Having a certain amount of pressure was statistically with lower VAS score ( = 0.033).
We found that postoperative colorectal cancer patients have a relatively high HRQOL but have poorer levels of anxiety/depression and pain/discomfort. Moreover, as the disease progresses and perceived economic pressure increases, the HRQOL of colorectal cancer patients shows a downward trend. Therefore, in daily clinical work, primary health physicians should pay attention to patient health management and economic toxicity, to improve patients' quality of life and reduce their economic pressure.
结直肠癌患者术后的感知经济负担和健康相关生活质量(HRQOL)研究有限,这有助于了解结直肠癌患者的健康状况,为制定干预措施、改善预后及提高患者生活质量提供依据。
采用基于问卷的在线调查,收集2023年11月至2024年3月期间结直肠癌术后患者的数据。根据《中国临床肿瘤学会(CSCO)结直肠癌诊疗指南2022版》,将结直肠癌严重程度分为1、2、3、4期。使用EQ-5D-5L中文版测量HRQOL。通过积分转换系统获得健康效用值,该系统对EQ-5D-5L量表中五个健康维度的不同水平赋予权重。采用单因素和多因素逻辑回归分析效用和视觉模拟评分(VAS)的相关因素。
共调查227例患者并纳入数据分析。患者平均年龄为63.55±11.71岁,个人年均收入60000元。随着癌症进展,HRQOL的不同维度呈恶化趋势。在疼痛/不适维度有轻微问题的患者更多,其次是焦虑/抑郁、日常活动、自我护理和行动能力。结直肠癌1、2、3、4期的EQ-VAS评分分别为87.99、90.85、77.04和78.28(P=0.000,χ²=63.036)。结直肠癌1、2、3、4期的效用评分分别为0.9443、0.9632、0.8759和0.8494(P=0.000,χ²=44.668)。与1期相比,3期和4期与较低的效用和VAS评分显著相关。拥有商业健康保险的患者VAS评分较高(P=0.029)。有一定压力的患者VAS评分较低(P=0.033)。
我们发现结直肠癌术后患者的HRQOL相对较高,但焦虑/抑郁和疼痛/不适水平较差。此外,随着疾病进展和感知经济压力增加,结直肠癌患者的HRQOL呈下降趋势。因此,在日常临床工作中,基层医疗医生应关注患者健康管理和经济毒性,以提高患者生活质量并减轻其经济压力。